DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Monobactam
Monobactam
WO 2015/179249 Al 26 November 2015 (26.11.2015) P O P C T
B-Lactams: Chemical Structure, Mode of Action and Mechanisms of Resistance
Penicillin Allergy Guidance Document
Computational Antibiotics Book
Management of Penicillin and Beta-Lactam Allergy
The Use of Natural Product Substrates for the Synthesis of Libraries of Biologically Active, New Chemical Entities
Anew Drug Design Strategy in the Liht of Molecular Hybridization Concept
Β-Lactam/Β-Lactamase Inhibitors for the Treatment of Infections Caused by Extended-Spectrum Β-Lactamase (ESBL)-Producing Enterobacteriaceae
Chemistry Classification Pharmacokinetics Clinical Uses And
A Thesis Entitled an Oral Dosage Form of Ceftriaxone Sodium Using Enteric
Antibiotics Currently in Clinical Development
Antibiotics Currently in Clinical Development
Impact of an Infectious Diseases Specialist-Led Antimicrobial
Gram Positive Cocci (GPC) Gram Neg (Rods = GNR) Anaerobes
Stembook 2018.Pdf
Antimicrobial Drugs 601
Antibiotics Currently in Global Clinical Development Note: This Data Visualization Was Updated in September 2018 with New Data
Trend of Antibiotic Usage for Hospitalized Community-Acquired
Top View
Antibiotic Adjuvants Â
( 12 ) United States Patent
Allergy to Penicillin and Betalactam Antibiotics
Antibiotic Formulations
Premier Health
Penicillin Allergy Cross-‐Reactivity • Roughly 10% of the Population
Norm Norm-Vet 2007
Guide to Antimicrobial Chemotherapy (PDF)
2019 Antibacterial Agents in Clinical Development
Penicillin and Beta-Lactam Allergy Management Document Type
Management of Allergy to Penicillins and Other Beta‐Lactams
Beta-Lactam Antibiotics and Vancomycin
Joint Report on Human and Animal Antibiotic Use, Sales and Resistance, 2013
Lactam Rings in Natural Products
Inhibition of Class a and C Β-Lactamases
Antibiotics in the Clinical Pipeline in October 2019
Discovery and Development of the Monobactams Author(S): R
Literature Search Strategy for Treatment of Stable
20 Progress—Development of New Drugs Active Against Gram-Negative Bacilli: an Update from the Infectious Diseases Society of America
A Survey of Medicine Use in Children and Adolescents in Austria
Antimicrobial Peptides As Anti-Infective Agents in Pre-Post-Antibiotic Era?
Antibiotic Formulations
In Vivo Evaluation of Tigemonam, a Novel Oral Monobactam JUNIUS M
Antibiotic Consumption in Non-Teaching Lebanese Hospitals 619
Synthesis and Antibacterial Activity of New Antibiotics Arising from Cephalosporin-Monobactam Coupling
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Medicines in Development ꟷ Antimicrobial Resistance (AMR)
Methicillin-Resistant Staphylococcus Aureus: Prevention and Treatment 2 Contact Hours
Comparison of Antibiotic Resistance Mechanisms in Antibiotic-Producing and Pathogenic Bacteria
Interaction Mode of the Novel Monobactam AIC499 Targeting Penicillin Binding Protein 3 of Gram-Negative Bacteria
An Overview of Beta-Lactam Antibiotics Bearing More Than One Pharmacophoric Group
ANTIBACTERIAL AGENTS in CLINICAL DEVELOPMENT an Analysis of the Antibacterial Clinical Development Pipeline, Including Tuberculosis
Antibiotics in the Clinical Pipeline in 2013
International Journal of Life Science and Pharma Research
New Carbapenemase Inhibitors: Clearing the Way for the -Lactams
1.3.1 Amoxicillin/Clavulanic Acid SPC, Labeling and Package Leaflet Common
Antimicrobial Overview June 2015 General Principles Aerobic Gram